COMPANY NEWS

Ur-Energy and Energy Fuels Announce U.S. Department of Commerce Has Initiated Investigation into Effects of Uranium Imports on U.S. National Security

DENVER, July 18, 2018 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels”) and Ur-Energy Inc. (NYSE American: URG; TSX: URE) (“Ur-Energy”) are pleased to announce that on July 18, 2018, the U.S. Department of Commerce (“DOC”) initiated an investigation into the effects of uranium imports on U.S. national security. This investigation was…

Details

July 18, 2018

Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.

Oxnard, CA – July xx, 2018 – CURE Pharmaceutical (OTCQB: CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet with Therapix Biosciences Ltd. (Nasdaq: TRPX), (“Therapix”), a specialty, clinical-stage pharmaceutical company developing cannabinoid-based treatments, to acquire the non-pain assets of Therapix, subject to the completion of…

Details

July 11, 2018

Energy Fuels Advancing Vanadium Acitivities; Strengthens Cash Position

Denver, Colorado – June 28, 2018 Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium and vanadium in the United States, is pleased to announce that it recently strengthened its cash position and currently has sufficient existing cash on hand to allow the Company the ability…

Details

June 28, 2018

Energy Fuels Set to Join Russell 3000

DENVER, June 18, 2018 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium and vanadium in the United States, is pleased to announce the Company is set to join the broad-market Russell 3000® Index at the conclusion of the Russell U.S. Indexes annual reconstitution,…

Details

June 19, 2018

CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference

GlobeNewswire•June 5, 2018 LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the O’Cannabiz Conference & Expo on June 9 at 2:50 PM ET in Toronto, Canada. Davidson will discuss “Maximizing and Understanding the Benefits of…

Details

June 5, 2018

CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational

LOS ANGELES, May 23, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 8th annual LD Micro Invitational on Monday, June 4th at 4 PM PT/ 7 PM ET at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. CEO Rob…

Details

May 23, 2018

Wealth Closes Oversubscribed Non-Brokered Private Placement

VANCOUVER, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) (WML.V) (WMLLF) (SSE:WMLCL) (Frankfurt:EJZ) announces it has closed an oversubscribed non-brokered private placement previously announced on May 7, 2018 (the “Placement”). A total of 5,678,236 units (the “Units”) were issued under the Placement at a price of $1.10 per…

Details

May 23, 2018

Wealth Announces Trinity Project Drill Program

May 07, 2018 08:00 ET | Source: Wealth Minerals Ltd VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) –– Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN), provides a Trinity Project (the “Project”) update. The Company is finalizing a drill contract and expects to begin drilling before the end of…

Details

May 7, 2018